Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1336 Views
-
Last post by frodo
-
- 0 Replies
- 983 Views
-
Last post by frodo
-
- 0 Replies
- 2304 Views
-
Last post by NHE
-
- 0 Replies
- 1279 Views
-
Last post by frodo
-
- 0 Replies
- 1246 Views
-
Last post by frodo
-
- 0 Replies
- 1211 Views
-
Last post by frodo
-
- 0 Replies
- 1475 Views
-
Last post by NHE
-
- 0 Replies
- 471 Views
-
Last post by NHE
-
- 1 Replies
- 2924 Views
-
Last post by Tif